Visitors Now:
Total Visits:
Total Stories:
Profile image
By ETF Daily News (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Valeant’s Top Shareholders Are Selling, But Are They Wrong?

Wednesday, November 2, 2016 8:09
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Image of multicolor pills in blister packValeant Pharmaceuticals Intl Inc (NYSE:VRX) is on the move again. Shares of the pharma giant spiked higher in afternoon trading yesterday on a WSJ report that the company was nearing a deal to sell its Salix business to Takeda Pharma for approximately $10 billion.

Valeant shares have been under extreme pressure over the past 12 months in the face of accounting scandals, political pressures from lawmakers, and concerns over its large debt loads. The Salix deal, if completed, would be a large injection of cash, alleviating investor concerns over the company’s financial situation.

Valeant had been trading at a multi-year low before yesterday’s news came out. Notable hedge funds and large institutional holders such as Ruane, Cuniff & Goldfarb’s Sequoia Fund, one of Valeant’s top shareholders, have been cutting losses and fleeing the stock this year.

VRX June 2016 13F Filings

Holder Change in position
RUANE, CUNNIFF & GOLDFARB INC (29,862,007)
JACKSON SQUARE PARTNERS, LLC (7,437,220)
EAGLE CAPITAL MANAGEMENT LLC (5,867,292)
HOUND PARTNERS, LLC (4,961,079)
TOURBILLON CAPITAL PARTNERS, L.P. (3,415,000)

Investors should note that Valeant is one of the top 25 holdings within the Sprott BUZZ Social Media Insights ETF (NYSE:BUZ). BUZ utilizes advanced artificial intelligence technology and natural language processing to analyze and measure sentiment across the social media landscape.

Tracking the BUZZ social media insights index (BUZZ), BUZ provides investors with exposure to stocks with the most bullish social momentum, rebalanced on a monthly basis. Valeant had remained out of the BUZZ index through the company’s downturn in 2015.

Interestingly, social sentiment picked up significantly in April this year as investors became bullish on the stock as a value play, propelling Valeant into one of the top holdings in BUZ, suggesting a turnaround may be in the works — and that the recent major shareholder selling might be a mistake.

About the Author: Jamie Wise
jamie-wiseJamie Wise is the Founder of BUZZ Indexes and the President and Chief Executive Officer of Periscope Capital, a Toronto-based hedge fund manager. BUZZ Indexes creates and maintains proprietary quantitative index and portfolio strategies based on Big Data analytics models. Established in 2009, Periscope Capital is an alternative investment asset manager focused on cross-asset arbitrage strategies. Previously, Mr. Wise was a managing director at Moore Capital Advisors Canada, a multi-strategy Canadian-focused hedge fund. Prior to Moore Capital, Mr. Wise was a Managing Director and Portfolio Manager at the Bank of Montreal where he led an internal proprietary trading group. At BMO, Mr. Wise was appointed the youngest Managing Director in the firm’s history. Mr. Wise has an undergraduate business degree (hons.), graduating first in his class from the Ivey School of Business at the University of Western Ontario in 1998. Mr. Wise holds a Chartered Financial Analyst (CFA) designation.

You are viewing an abbreviated republication of ETF Daily News content. You can find full ETF Daily News articles on (www.etfdailynews.com)

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.